Expert Insights
Content Hubs
Themes
Active ETFs
Free Cash Flow
Alternatives
Future ETFs
Artificial Intelligence
Innovative ETFs
China Insights
Institutional Income Strategies
CoinShares
Leveraged & Inverse
Core Strategies
Market Insights
Crypto
Market Outlooks
Disruptive Technology
Modern Alpha
Energy Infrastructure
Nuclear Energy
ETF Building Blocks
Portfolio Strategies
ETF Investing
Sector Investing
ETF Strategist
Tax Efficient Income
Financial Literacy
Thematic Investing
Fixed Income
Asset Class
Equity
U.S. Equity
Int'l Developed
Emerging Market Equities
Smart Beta
Fixed Income
High Yield Corporates
Int'l Fixed Income
Investment Grade Corporates
US Treasuries & TIPS
Alternatives
Gold/Silver/Critical Materials
Commodities
Cryptocurrency
Currency
Volatility
ETF Ecosystem
ETFs in Canada
Exchange
CoinShares
Webcasts
Popular ETFs
SPY – SPDR S&P 500 ETF
VOO – Vanguard S&P 500 ETF
QQQ – Invesco QQQ ETF
GLD – SPDR Gold Shares ETF
IVV – iShares Core S&P 500 ETF
EFA - iShares MSCI EAFE ETF
IEMG – iShares Core MSCI Emerging Markets ETF
EEM – iShares MSCI Emerging Markets ETF
VTI – Vanguard Total Stock Market ETF
GDX - VanEck Vectors Gold Miners ETF
XLF - Financial Select Sector SPDR Fund
VEA – Vanguard FTSE Developed Markets ETF
VTV - Vanguard Value ETF
Top Gold ETFs
Top Oil ETFs
Top Commodity ETFs
Top Hedge Fund ETFs
Top Financials ETFs
Top Inverse Equities ETFs
Top High Yield Bond ETFs
Education & Media
Newsletter
New ETFs
Education Central
Videos
ETF of the Week Podcast
ETF Prime Podcast
ETF 360 Video Series
Gaining Perspective
Sectors
Sector Investing Content Hub
Sector Power Rankings
XLK
XLE
XLI
XLC
XLU
XLF
XLY
XLV
XLP
XLB
XLRE
Events
Asset Allocation Summit
2027 Market Outlook
Q2 Market Outlook
Winter Symposium
Midyear Market Outlook
Company
About VettaFi
Healthcare
Equity ETFs
How ETF Investors Reacted to the Volatility
By
Tom Lydon
January 26, 2016
Equity ETFs
Disappointing Drug Trials Drag on Biotech ETFs
By
Tom Lydon
January 21, 2016
Equity ETFs
Sector ETFs That Could Escape the Earnings Malaise
By
Tom Lydon
January 14, 2016
New ETFs
New ETF Aims Strategically at Generic Drug Industry
By
Tom Lydon
January 13, 2016
Equity ETFs
Sector ETFs to Watch This Earnings Season
By
Tom Lydon
January 11, 2016
Equity ETFs
Biotech ETFs Look Green on Earnings Concerns
By
Tom Lydon
January 11, 2016
Featured
Health Care ETFs in the Year Ahead
By
Tom Lydon
December 24, 2015
Featured
ETF Performance Report: November
By
Tom Lydon
November 30, 2015
Featured
Sector ETFs for the Late Business Cycle
By
Tom Lydon
November 25, 2015
Featured
Obamacare Making Health Care Provider ETFs Sick
By
Tom Lydon
November 19, 2015
Featured
Biotech ETFs Start Week With A Surge
By
Tom Lydon
November 2, 2015
Featured
Major Pharma Merger Boosts ETFs
By
Tom Lydon
October 29, 2015
Featured
2 Reasons Consumer Discretionary ETFs Will Finish 2015 Strong
By
Tom Lydon
October 29, 2015
Featured
Pharma ETFs Valiantly Fight Valeant Drag
By
Tom Lydon
October 15, 2015
New ETFs
The First Cancer Immunotherapy ETF
By
Tom Lydon
October 14, 2015
Featured
Two Big Factors Hurting Biotech ETFs
By
Tom Lydon
October 6, 2015
New ETFs
John Hancock Makes ETF Debut
By
Tom Lydon
September 29, 2015
Contributed
Health Care: The Stealth Retirement Expense
By
BlackRock
August 21, 2015
Previous
1
…
16
17
18
19
20
21
Next
X